x
ServiziMenu principaleHome
You are here: Home > Events > Future Events > Breast Cancer in Young Women: Fifth ESO-ESMO International Symposium
Print

Description




Co-Chairs:
O.Pagani, CH - S. Paluch-Shimon, IL
Scientific Committee: F. Cardoso, PT - N. Harbeck, DE - A.H. Partridge, US - F.A. Peccatori, IT - E. Senkus, PL


FOREWORD
Breast cancer in young women is a complex disease, occurring when these women are at the peak of their reproductive years, family life and careers. Being a somewhat rare disease, the optimal management of these patients is based on scientific data derived from clinical trials mostly conducted on older women. Many aspects of breast cancer in young women are therefore poorly understood (e.g. etiology and biology among others) and research is much needed in this field. In addition, young women have many years ahead of them to suffer the long-term effects of treatment and specific survivorship issues (fertility and job among others). This fifth event is a new opportunity for the latest updates on this field and a platform for generating future research concepts and collaborations. It will cover challenges and opportunities in different cultural and economic settings, follow-up care, guidelines and challenges in the management of ABC in young women. It will also include a Consensus Session that will form the basis for a Consensus Guidelines manuscript to be published after the Symposium.
We hope that you will join us and contribute to further develop the understanding and treatment of this disease.

Olivia Pagani
On behalf of the Co-Chair and the Scientific Committee Members


LEARNING OBJECTIVES
• In depth learning and update of the scientific and clinical aspects of breast cancer in young women
• Highlight the importance of multi-disciplinary management and discuss difficult clinical cases
• Focus on clinical research priorities and future perspectives, involving patients’ advocates in setting the agenda
• Participate in the discussion of consensus guidelines

MAIN TOPICS
• Biology
• World perspective in epidemiology and treatment
• Hereditary breast cancer
• Loco-regional therapy
• Systemic therapy
• Psychosocial aspects and survivorship


BCY5 is supported by the ABC Global Alliance, the Breast Cancer Research Foundation and Dana Farber Cancer Institute

               


The patient workshop is supported by Anna dai Capelli Corti



Faculty

FACULTY
O. Abulkhair, King Abdulaziz Medical City for National Guard, Riyadh, SA
M. Bergomi, Hirslanden Oncology Centre, Zurich, CH
G. Bianchi Micheli
, Southern Switzerland Breast Center (CSSI), Viganello, Lugano, CH
I. Bozovic -Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, RS
M. Braun, Shani Shaare Zedek Medical Centre, Jerusalem, IL
F. Cardoso, Champalimaud Clinical Center, Lisbon, PT
M.J. Cardoso, Champalimaud Clinical Center, Lisbon, PT
E. Copson, University Hospital Southampton, Southampton, UK
G. Curigliano, European Institute of Oncology, Milan, IT
S.B. Kim, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, KR
N.S. El Saghir, American University of Beirut Medical Center, Beirut, LB
A. Eniu, Riviera-Chablais Vaud-Valais, Breast Unit, Vevey, CH
T. Ferreiro, Baby Beatles, Barcelona, ES
J.E. Garber, Dana-Farber Cancer Institute, Boston, US
K. Gelmon, BC Cancer Agency, Vancouver, CA
O.D. Gentilini, IRCCS Ospedale San Raffaele, Milan, IT
R. Graffeo, Oncology Institute of Southern Switzerland (IOSI), Lugano, CH
N. Harbeck, University of Munich (LMU), Munich, DE
B. Kaufman, Sheba Medical Center, Ramat Gan, IL
M. Lambertini, Policlinico San Martino Hospital – University of Genoa, Genoa, IT
Q. Liu, Sun Yat-sen Memorial Hospital,Sun Yat-sen University, Guangzhou, CN
S. Loibl, German Breast Group, GBG Forschungs GmbH, Neu- Isenburg, DE
F. Meani, Lugano Regional Hospital, Lugano, CH
J. Merschdorf, Young Survival Coalition, New York, US
O. Pagani, Oncology Institute of Southern Switzerland (IOSI), Bellizona, CH
S. Paluch-Shimon, Shani Shaare Zedek Medical Centre, Jerusalem, IL
A.H. Partridge, Dana-Farber Cancer Institute, Boston, US
F.A. Peccatori, European Institute of Oncology, Milan, IT
G. Pruneri, National Cancer Institute - Foundation IRCCS, Milan, IT
A. Richetti, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
L. Rossi, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
E. Senkus, Medical University of Gdansk, Gdansk, PL
B. Sirohi, Max Institute of Cancer Care, New Delhi & Gurgaon, IN
T. Spanic, Europa Donna Slovenia, Ljubljana, SI
I. Vaz-Luis, Gustave Roussy Institute, Villejuif, FR
V.A. Vitale, Southern Switzerland Breast Center (CSSI), Viganello, Lugano, CH


CONSENSUS PANELLISTS
O. Abulkhair, SA
G. Bianchi, CH
F. Cardoso, PT
M.J. Cardoso, PT
G. Curigliano, IT
J.E. Garber, US
K. Gelmon, CA
O.D. Gentilini, IT
B. Kaufman, IL
S.B. Kim, KR
Q. Liu, CN
S. Loibl, DE
J. Merschdorf, US
S. Paluch-Shimon, IL
O. Pagani, CH
A.H. Partridge, US
F.A. Peccatori, IT
G. Pruneri, IT
E. Senkus, PL
B. Sirohi, IN/UK
T. Spanic, SI


General information

ORGANISING SECRETARIAT

Organisation and Programme
Francesca Marangoni (1)
email: fmarangoni@eso.net
phone: +39 02 85464525

Faculty and travel grants
Dolores Knupfer (2)
email: dknupfer@eso.net
phone: +41 91 8200952

Registrations
Corinne Hall (1)
email: chall@eso.net
phone: +41 91 8200958

(1) European School of Oncology, Via Turati 29, 20123 Milan, Italy
(2) European School of Oncology, Piazza Indipendenza 2, 6500 Bellinzona, Switzerland

VENUE

Palazzo dei Congressi Lugano - Piazza Indipendenza 4, 6900 Lugano, Switzerland

OFFICIAL LANGUAGE
The official language will be English. No translation will be provided.

INSURANCE
The organisers bear no responsibility for untoward events in relation to the participation in the Conference. Participants are advised to take out their own personal and travel insurance coverage.

CME ACCREDITATION CERTIFICATES
Participants will be issued a certificate of attendance.
Application for CME recognition will be submitted to the Accreditation Council of Oncology in Europe (ACOE) and to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA).
Information on the status of the applications can be obtained from the organising secretariat.
ESMO-MORA credits will be granted by ESMO.

IMPORTANT DEADLINES

Travel grant: 10 May 2020  
Early registration: 21 June 2020  
Late registration by: 27 September 2020  
Onsite registration from: 28 September 2020  
Onsite registration from: insert the date  

Registration

PARTICIPANT’S PROFILE
• Medical oncologists
• Surgeons
• Gynaecologists
• Radiation oncologists
• Breast radiologists
• Onco-geneticists
• Pathologists
• Nurses
• Patient advocates
• Psycho-Oncologists

REGISTRATION
Due to the current situation with COVID-19 we are currently investigating a new format for BCY5. Further details will follow shortly.

 

Accommodation

HOTEL ACCOMMODATION
For hotel accommodation in Lugano, please book online HERE.

Programme

15 October

BCY5 WORKSHOP FOR PATIENTS and PATIENTS ADVOCATES:
What should you know about breast cancer in young women (supported by “Anna dai capelli corti”)
PART I
14:00 Diagnostic challenges
V.A Vitale, CH
14:15 Principles of genetic predisposition and counselling
R. Graffeo,CH
14:35 How to interpret the pathology report
G. Pruneri, IT
14:50 Principles of surgery
F. Meani, CH
15:10 Principles of radiation therapy
A. Richetti, CH
15:30 Principles of systemic therapies in early breast cancer and management of early and late treatment side effects (including contraception, gynecological problems, fertility and pregnancy desire) 
E. Senkus, PL
16:00 Strategies for patients’ and family support
G. Bianchi, CH
16:20 Questions and answers
16:40 Coffee break
PART II
17:10 Principles of systemic therapies in advanced breast cancer
F. Cardoso, PT
17:30 The importance of multidisciplinary care
A. Partridge, US
17:50 Principles of clinical research
L. Rossi, CH
18:05 Questions and answers
18:30 Patient Advocate Agenda
Young patient advocate workshop including patient advocate messages to be agreed for input into last session statement
Chairs: J. Merschdorf, US - T. Spanic, SI
19:00 Close

16 October

OPENING SESSION
Chair: O. Pagani, CH - S. Paluch-Shimon, IL
9:00 Welcome by host chair
O. Pagani, CH
9:15 Welcome by Cantonal Authorities
9:25 KEYNOTE 1: Presentation by young patient
T. Ferreiro, ES
9:40 KEYNOTE 2 (in collaboration with Dana Farber Cancer Institute):
Young women with BC: challenges and opportunities in high-income countries
A. Partridge, US
SESSION 1: BCY CHALLENGES AND OPPORTUNITIES IN DIFFERENT CULTURAL AND
ECONOMIC SETTINGS
Chair: O. Pagani, CH
10:00 Strategies to support breast cancer care in low- and middle-income countries

- The Silk project (F.A. Peccatori, IT)
- The Global alliance (F. Cardoso, PT)
  (Moderator: I. Bozovic-Spasojevic, RS)

10:30 Round table: BCY in Middle East
O. Abulkhair, SA -B. Kaufman, IL - N.S. El Saghir, LB
(Moderator: E. Senkus, PL)
11:00 Round table: BCY in Far East
S.B. Kim, KR - Q. Liu, CN - B. Sirohi, IN/UK
11:30 Coffee break
SESSION 2: CHALLENGES IN THE MANAGEMENT OF ABC IN YOUNG WOMEN
Chair: F.A. Peccatori, IT
12:00 Terminal care and end of life issues
K. Gelmon, CA
12:20 Can you go through the rain without getting wet? Compassion fatigue in the oncology setting
M. Braun, IL
12.40 Discussion
13:00 Lunch
SESSION 3: WHAT SHOULD WE CHANGE IN BCY5 GUIDELINES?
Chair: S. Paluch-Shimon, IL
14:00 Preoperative systemic treatment
N. Harbeck, DE
14:20 Tumor biology
G. Pruneri, IT
14:35 Familial and hereditary breast cancer
J.E. Garber, US
14:55 Adjuvant chemo- and targeted therapies
G. Curigliano, IT
15:15 Adjuvant endocrine therapy
O. Pagani, CH
15:30 What is new in the management of ABC in young women: highlights from ABC5
F. Cardoso, PT
16:50 Coffee break
17:00 Mastectomy is better than breast conserving surgery
- In favor (M.J. Cardoso, PT)
- Against (O. Gentilini, IT)
(Moderator: A. Richetti, CH)
17:05 BC during pregnancy
S. Loibl, DE
17:20 Discussion
17:40 KEYNOTE 3 Life-style habits and interventions in young women with breast cancer: evidence from clinical research
E. Copson, UK
Moderator: M. Bergomi, CH
18:10 Summary statement on behalf of the Young Women Advocates
J. Merschdorf, US - T. Spanic, SI
18:30 Close

17 October

SESSION 4: FOLLOW-UP CARE
Chair: A.H. Partridge, US
8:30 Fertility in mutation carriers
M. Lambertini, IT
8:50 Survivorship issues in clinical research
S Paluch-Shimon, IL
9:10 e-PROMS: do they really change patient care?
Investigator from Breast Unit of Southern Switzerland
(Moderator I. Vaz Duarte Luis, FR)
9:30 Discussion
9:45 Coffee break
SESSION 5: BREAST CANCER IN YOUNG WOMEN INTERNATIONAL CONSENSUS GUIDELINES
12:30 Close

 

Follow us